Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Appears to function in the U7 snRNP complex that is involved in histone 3'-end processing. Additionally we are shipping SNRPE Proteins (15) and SNRPE Kits (13) and many more products for this protein.
Showing 10 out of 136 products:
Human Monoclonal SNRPE Primary Antibody for WB - ABIN968839
Barnier, Papin, Eychène, Lecoq, Calothy: The mouse B-raf gene encodes multiple protein isoforms with tissue-specific expression. in The Journal of biological chemistry 1995
Show all 4 references for ABIN968839
Human Polyclonal SNRPE Primary Antibody for IHC (p), WB - ABIN392253
Hingorani, Jacobetz, Robertson, Herlyn, Tuveson: Suppression of BRAF(V599E) in human melanoma abrogates transformation. in Cancer research 2003
Show all 3 references for ABIN392253
Human Polyclonal SNRPE Primary Antibody for FACS, IF - ABIN392249
Davies, Bignell, Cox, Stephens, Edkins, Clegg, Teague, Woffendin, Garnett, Bottomley, Davis, Dicks, Ewing, Floyd, Gray, Hall, Hawes, Hughes, Kosmidou, Menzies, Mould, Parker, Stevens, Watt, Hooper et al.: Mutations of the BRAF gene in human cancer. ... in Nature 2002
Show all 3 references for ABIN392249
Human Polyclonal SNRPE Primary Antibody for FACS, IF - ABIN392246
Frattini, Ferrario, Bressan, Balestra, De Cecco, Mondellini, Bongarzone, Collini, Gariboldi, Pilotti, Pierotti, Greco: Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer. in Oncogene 2004
Show all 2 references for ABIN392246
Human Polyclonal SNRPE Primary Antibody for ELISA, WB - ABIN1450695
Hillier, Fulton, Fulton, Graves, Pepin, Wagner-McPherson, Layman, Maas, Jaeger, Walker, Wylie, Sekhon, Becker, OLaughlin, Schaller, Fewell, Delehaunty, Miner, Nash, Cordes, Du, Sun, Edwards et al.: The DNA sequence of human chromosome 7. ... in Nature 2003
Show all 2 references for ABIN1450695
Human Polyclonal SNRPE Primary Antibody for IF, IHC - ABIN1533622
Eychène, Barnier, Apiou, Dutrillaux, Calothy: Chromosomal assignment of two human B-raf(Rmil) proto-oncogene loci: B-raf-1 encoding the p94Braf/Rmil and B-raf-2, a processed pseudogene. in Oncogene 1992
Show all 2 references for ABIN1533622
Human Polyclonal SNRPE Primary Antibody for ELISA, WB - ABIN1532127
Scherer, Cheung, MacDonald, Osborne, Nakabayashi, Herbrick, Carson, Parker-Katiraee, Skaug, Khaja, Zhang, Hudek, Li, Haddad, Duggan, Fernandez, Kanematsu, Gentles, Christopoulos, Choufani, Kwasnicka et al.: Human chromosome 7: DNA sequence and biology. ... in Science (New York, N.Y.) 2003
these results suggest that the activation of 5-HT1D receptors selectively enhanced IA via the Gbetagamma of the Go-protein, PKA, and the sequential B-Raf-dependent p38 MAPK (show MAPK14 Antibodies) signaling cascade.
BRAF (show BRAF Antibodies) V600E inhibition stimulates AMP-activated protein kinase (show PRKAA2 Antibodies)-mediated autophagy in colorectal cancer cells.
these data confirm the existence of a negative feedback pathway by which BRAF (show BRAF Antibodies) protein stability is regulated by ERK (show EPHB2 Antibodies).
coexpression of BRAF (show BRAF Antibodies)(V600E) and KRAS(G12D) in early tumorigenesis leads to negative selection due to oncogene (show RAB1A Antibodies)-induced senescence
findings suggest that targeting ErbB-3 (show ERBB3 Antibodies) receptors could represent an effective therapeutic approach in BRAF (show BRAF Antibodies)-V600E mutant colon cancer
Atg7 (show ATG7 Antibodies) Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma
Cotargeting is the treatment for mutant RAF (show RAF1 Antibodies)/MEK (show MDK Antibodies)/ERK (show EPHB2 Antibodies) and NF-kB pathways to treat mutant BRAF (show BRAF Antibodies) melanomas.
The CM cell lines, as well as the tumor xenografts and their metastases, were positive for the melanoma markers HMB-45, S100B (show S100B Antibodies), and MART-1 (show RTL1 Antibodies). Two cell lines and their corresponding xenografts carried a BRAF (show BRAF Antibodies) mutation, the third showed an NRAS (show NRAS Antibodies) mutation.
New BRAF (show BRAF Antibodies) knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardiofaciocutaneous syndrome.
Results demonstrate that BRAF (show BRAF Antibodies) activates Usp5 (show USP5 Antibodies) to suppress cell cycle checkpoint control and apoptosis by blocking p53 (show TP53 Antibodies) and FAS (show FAS Antibodies) induction.
Overexpression of SNRPE is associated with highly aggressive breast cancers.
Mutations in SNRPE, which encodes a core protein of the spliceosome, cause autosomal-dominant hypotrichosis simplex
In the SME intron, the position of the branchpoint A residue within the region base paired with U12 differs from that in P120 (show HNRNPU Antibodies) and XTF.
growth arrest by SmE directly correlates with the reduction of cyclin E (show CCNE1 Antibodies), CDK2 (show CDK2 Antibodies), CDC25C (show CDC25C Antibodies) and CDC2 (show CDK1 Antibodies) expression, and up-regulation of p27Kip
Appears to function in the U7 snRNP complex that is involved in histone 3'-end processing. Associated with snRNP U1, U2, U4/U6 and U5 (By similarity).
small nuclear ribonucleoprotein polypeptide E
, B-Raf proto-oncogene serine/threonine-protein kinase (p94)
, proto-oncogene B-Raf
, serine/threonine-protein kinase B-raf
, sm protein E
, small nuclear ribonucleoprotein E
, SmE protein
, v-raf murine sarcoma viral oncogene homolog B1